Portal Vein Stent Placement in Five Patients with Chronic Portal Vein Thrombosis Prior to Pancreatic Surgery

Ugo Scemama; David Jérémie Birnbaum; Mehdi Ouaissi; Olivier Turrini; Vincent Moutardier; Jérôme Soussan

doi:10.1016/j.jvir.2015.11.057

Portal Vein Stent Placement in Five Patients with Chronic Portal Vein Thrombosis Prior to Pancreatic Surgery

J Vasc Interv Radiol. 2016 Jun;27(6):889-94. doi: 10.1016/j.jvir.2015.11.057. Epub 2016 Jun 3.

Authors

Ugo Scemama¹, David Jérémie Birnbaum², Mehdi Ouaissi³, Olivier Turrini⁴, Vincent Moutardier², Jérôme Soussan⁵

Affiliations

¹ Imaging Department, Hôpital Nord and Aix-Marseille Université, Chemin des Bourrely, Marseille 13915, France. Electronic address: ugo.scemama@gmail.com.
² Department of Digestive Surgery, Hôpital Nord and Aix-Marseille Université, Chemin des Bourrely, Marseille 13915, France.
³ Department of Digestive Surgery, Hopital La Timone and Aix-Marseille Université, Marseille, France.
⁴ Department of Digestive Surgery, Institut Paoli Calmette and Aix-Marseille Université, Marseille, France.
⁵ Imaging Department, Hôpital Nord and Aix-Marseille Université, Chemin des Bourrely, Marseille 13915, France.

PMID: 27287970
DOI: 10.1016/j.jvir.2015.11.057

Abstract

Five patients with pancreatic tumors and chronic portal vein (PV) thrombosis underwent PV stent placement before surgery. The patients either had resectable tumors or locally advanced tumors with stable, partial, or complete response to neoadjuvant therapy. PV stent placement removed periportal collaterals in all cases, with no complications, in a mean time of 150 minutes. Patients received a daily dose of subcutaneous low-molecular-weight heparin until 12 hours before surgery, and low-molecular-weight heparin was resumed for 30 days after surgery. Surgery was performed 1 day to 3 months after PV stent placement, with no complications related to periportal collaterals.

MeSH terms

Adult
Aged
Anticoagulants / administration & dosage
Blood Vessel Prosthesis Implantation
Chronic Disease
Collateral Circulation
Computed Tomography Angiography
Endovascular Procedures / instrumentation*
Female
Heparin, Low-Molecular-Weight / administration & dosage
Humans
Male
Middle Aged
Pancreatic Neoplasms / complications
Pancreatic Neoplasms / pathology
Pancreatic Neoplasms / surgery*
Pancreaticoduodenectomy*
Phlebography / methods
Portal Vein* / diagnostic imaging
Portal Vein* / physiopathology
Portal Vein* / surgery
Regional Blood Flow
Retrospective Studies
Stents*
Time Factors
Treatment Outcome
Venous Thrombosis / complications
Venous Thrombosis / diagnostic imaging
Venous Thrombosis / therapy*

Substances

Anticoagulants
Heparin, Low-Molecular-Weight